Compare
Henry Schein vs Lilly (Eli) (HSIC vs LLY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Henry Schein (HSIC) returned +19.5% and Lilly (Eli) (LLY) +46.2%; so far this year the figures are +13.8% and +26.0%.
Lilly (Eli) is the larger company by market value, about 133.9 times the size of Henry Schein.
On trailing earnings, HSIC trades at 23.6 times and LLY at 43.9 times.
Revenue grew +6.2% at HSIC and +45.5% at LLY over the last year.
HSIC pays no dividend. LLY yields 0.49%.
Data as of the latest close. Not investment advice.
Relative performance
| HSIC | LLY | |
|---|---|---|
| Price | $86.05 | $1,354.00 |
| 1-day | +0.87% | -0.79% |
| YTD | +13.85% | +25.99% |
| 1 year | +19.50% | +46.25% |
| 3 years | +34.31% | +144.20% |
| Market cap | $9.5B | $1.27T |
| P/E | 23.6 | 43.9 |
| P/S | 0.69 | 14.73 |
| P/B | 3.01 | 31.63 |
| Revenue growth | +6.20% | +45.50% |
| EPS growth | +15.10% | +50.70% |
| Gross margin % | 31.6 | 83.6 |
| Net margin % | 3.1 | 31.9 |
| ROE % | 13.3 | 68.5 |
| Debt / equity | 1.07 | 1.23 |
| FCF yield % | 5.9 | 2.4 |
| Dividend yield % | — | 0.49 |
| Beta | 0.62 | 0.29 |
| RSI (14) | 51.3 | 61.1 |
| Technical rating |